Selected research
Industry Research
OTC Gastrointestinal Products Industry Research Report 2026
Market perspective
The global OTC Gastrointestinal Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for OTC Gastrointestinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for OTC Gastrointestinal Products is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for OTC Gastrointestinal Products is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of OTC Gastrointestinal Products include Novartis, Merck, Pfizer, GlaxoSmithKline, Bayer and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global OTC Gastrointestinal Products market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
OTC Gastrointestinal Products Market by Company
Novartis
Merck
Pfizer
GlaxoSmithKline
Bayer
Bristol-Myers Squibb
OTC Gastrointestinal Products Segment by Type
H2 Receptor Antagonists
Proton Pump Inhibitors (PPIs)
OTC Gastrointestinal Products Segment by Application
E-Commerce
Retail Stores
Drug Stores
Hospital Pharmacies
OTC Gastrointestinal Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Gastrointestinal Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of OTC Gastrointestinal Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Gastrointestinal Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of OTC Gastrointestinal Products manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of OTC Gastrointestinal Products by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of OTC Gastrointestinal Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- H2 Receptor Antagonists
- Proton Pump Inhibitors (PPIs)
Applications
- E-Commerce
- Retail Stores
- Drug Stores
- Hospital Pharmacies
Companies covered
- Novartis
- Merck
- Pfizer
- GlaxoSmithKline
- Bayer
- Bristol-Myers Squibb
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global OTC Gastrointestinal Products Market Size (2021-2032)
- 2.2.2 Global OTC Gastrointestinal Products Sales (2021-2032)
- 2.2.3 Global OTC Gastrointestinal Products Market Average Price (2021-2032)
- 2.3 OTC Gastrointestinal Products by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 H2 Receptor Antagonists
- 2.3.3 Proton Pump Inhibitors (PPIs)
- 2.4 OTC Gastrointestinal Products by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 E-Commerce
- 2.4.3 Retail Stores
- 2.4.4 Drug Stores
- 2.4.5 Hospital Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global OTC Gastrointestinal Products Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global OTC Gastrointestinal Products Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global OTC Gastrointestinal Products Revenue of Manufacturers (2021-2026)
- 3.4 Global OTC Gastrointestinal Products Average Price by Manufacturers (2021-2026)
- 3.5 Global OTC Gastrointestinal Products Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of OTC Gastrointestinal Products, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of OTC Gastrointestinal Products, Product Type & Application
- 3.8 Global Manufacturers of OTC Gastrointestinal Products, Established Date
- 3.9 Global OTC Gastrointestinal Products Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis
- 4.1.1 Novartis Company Information
- 4.1.2 Novartis Business Overview
- 4.1.3 Novartis OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis OTC Gastrointestinal Products Product Portfolio
- 4.1.5 Novartis Recent Developments
- 4.2 Merck
- 4.2.1 Merck Company Information
- 4.2.2 Merck Business Overview
- 4.2.3 Merck OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck OTC Gastrointestinal Products Product Portfolio
- 4.2.5 Merck Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer OTC Gastrointestinal Products Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 GlaxoSmithKline
- 4.4.1 GlaxoSmithKline Company Information
- 4.4.2 GlaxoSmithKline Business Overview
- 4.4.3 GlaxoSmithKline OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline OTC Gastrointestinal Products Product Portfolio
- 4.4.5 GlaxoSmithKline Recent Developments
- 4.5 Bayer
- 4.5.1 Bayer Company Information
- 4.5.2 Bayer Business Overview
- 4.5.3 Bayer OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bayer OTC Gastrointestinal Products Product Portfolio
- 4.5.5 Bayer Recent Developments
- 4.6 Bristol-Myers Squibb
- 4.6.1 Bristol-Myers Squibb Company Information
- 4.6.2 Bristol-Myers Squibb Business Overview
- 4.6.3 Bristol-Myers Squibb OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bristol-Myers Squibb OTC Gastrointestinal Products Product Portfolio
- 4.6.5 Bristol-Myers Squibb Recent Developments
5 Global OTC Gastrointestinal Products Market Scenario by Region
- 5.1 Global OTC Gastrointestinal Products Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global OTC Gastrointestinal Products Sales by Region: 2021-2032
- 5.2.1 Global OTC Gastrointestinal Products Sales by Region: 2021-2026
- 5.2.2 Global OTC Gastrointestinal Products Sales by Region: 2027-2032
- 5.3 Global OTC Gastrointestinal Products Revenue by Region: 2021-2032
- 5.3.1 Global OTC Gastrointestinal Products Revenue by Region: 2021-2026
- 5.3.2 Global OTC Gastrointestinal Products Revenue by Region: 2027-2032
- 5.4 North America OTC Gastrointestinal Products Market Facts & Figures by Country
- 5.4.1 North America OTC Gastrointestinal Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America OTC Gastrointestinal Products Sales by Country (2021-2032)
- 5.4.3 North America OTC Gastrointestinal Products Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe OTC Gastrointestinal Products Market Facts & Figures by Country
- 5.5.1 Europe OTC Gastrointestinal Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe OTC Gastrointestinal Products Sales by Country (2021-2032)
- 5.5.3 Europe OTC Gastrointestinal Products Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific OTC Gastrointestinal Products Market Facts & Figures by Country
- 5.6.1 Asia Pacific OTC Gastrointestinal Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific OTC Gastrointestinal Products Sales by Country (2021-2032)
- 5.6.3 Asia Pacific OTC Gastrointestinal Products Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America OTC Gastrointestinal Products Market Facts & Figures by Country
- 5.7.1 South America OTC Gastrointestinal Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America OTC Gastrointestinal Products Sales by Country (2021-2032)
- 5.7.3 South America OTC Gastrointestinal Products Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa OTC Gastrointestinal Products Market Facts & Figures by Country
- 5.8.1 Middle East and Africa OTC Gastrointestinal Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa OTC Gastrointestinal Products Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa OTC Gastrointestinal Products Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global OTC Gastrointestinal Products Sales by Type (2021-2032)
- 6.1.1 Global OTC Gastrointestinal Products Sales by Type (2021-2032) & (k units)
- 6.1.2 Global OTC Gastrointestinal Products Sales Market Share by Type (2021-2032)
- 6.2 Global OTC Gastrointestinal Products Revenue by Type (2021-2032)
- 6.2.1 Global OTC Gastrointestinal Products Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global OTC Gastrointestinal Products Revenue Market Share by Type (2021-2032)
- 6.3 Global OTC Gastrointestinal Products Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global OTC Gastrointestinal Products Sales by Application (2021-2032)
- 7.1.1 Global OTC Gastrointestinal Products Sales by Application (2021-2032) & (k units)
- 7.1.2 Global OTC Gastrointestinal Products Sales Market Share by Application (2021-2032)
- 7.2 Global OTC Gastrointestinal Products Revenue by Application (2021-2032)
- 7.2.1 Global OTC Gastrointestinal Products Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global OTC Gastrointestinal Products Revenue Market Share by Application (2021-2032)
- 7.3 Global OTC Gastrointestinal Products Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 OTC Gastrointestinal Products Value Chain Analysis
- 8.1.1 OTC Gastrointestinal Products Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 OTC Gastrointestinal Products Production Mode & Process
- 8.2 OTC Gastrointestinal Products Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 OTC Gastrointestinal Products Distributors
- 8.2.3 OTC Gastrointestinal Products Customers
9 Global OTC Gastrointestinal Products Analyzing Market Dynamics
- 9.1 OTC Gastrointestinal Products Industry Trends
- 9.2 OTC Gastrointestinal Products Industry Drivers
- 9.3 OTC Gastrointestinal Products Industry Opportunities and Challenges
- 9.4 OTC Gastrointestinal Products Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst